Evidence map›Paper›PMID 38867733›Full record

ReviewiMeta2022

Applications of de Bruijn graphs in microbiome research.

Keith Dufault-Thompson, Xiaofang Jiang

Abstract readReview
In one paragraph

Review in iMeta, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Keith Dufault-ThompsonIntramural Research Program National Library of Medicine, National Institutes of Health Bethesda Maryland USA.
Xiaofang JiangIntramural Research Program National Library of Medicine, National Institutes of Health Bethesda Maryland USA.ORCID 0000-0002-0955-8284

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-throughput sequencing has become an increasingly central component of microbiome research. The development of de Bruijn graph-based methods for assembling high-throughput sequencing data has been an important part of the broader adoption of sequencing as part of biological studies. Recent advances in the construction and representation of de Bruijn graphs have led to new approaches that utilize the de Bruijn graph data structure to aid in different biological analyses. One type of application of these methods has been in alternative approaches to the assembly of sequencing data like gene-targeted assembly, where only gene sequences are assembled out of larger metagenomes, and differential assembly, where sequences that are differentially present between two samples are assembled. de Bruijn graphs have also been applied for comparative genomics where they can be used to represent large sets of multiple genomes or metagenomes where structural features in the graphs can be used to identify variants, indels, and homologous regions in sequences. These de Bruijn graph-based representations of sequencing data have even begun to be applied to whole sequencing databases for large-scale searches and experiment discovery. de Bruijn graphs have played a central role in how high-throughput sequencing data is worked with, and the rapid development of new tools that rely on these data structures suggests that they will continue to play an important role in biology in the future.

Indexed as

de Bruijn graphsmicrobiomeOmics

Identifiers

PMID38867733
PMCPMC10989854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.